“Progress in science depends on new techniques, new discoveries and new ideas, probably in that order”  

Sydney Brenner, Nobel Price Winner 2002 in physiology and medicine

OUR MISSION

To bring on the market a new generation of product, alternative to animal experimentation, that better predict efficacy and safety of any molecule based on human tissue.


OUR VISION

We are convinced that experimentation for scientific purposes based on animal models will be forbidden by 2030 in North America and Europe

OUR MAIN PRODUCT

Based on our patented microfluidic technology our product allow us to culture and mimic any human organ in physio-pathological condition


Cherry-Biotech_Microfluidic-chip

OUR CONTEXT TODAY

As deeptech entrepreneurs, we choose the entrepreneurial path instead of academic’s one. As deeptech entrepreneurs, we are highly risk takers team and needs to do more with less. We are now at the early stage of development of our company before product market fit. We are at a pre-sales phase of our main product (Cubix).


Cherry-Biotech_Corporate-Information

human-on-a-chip-organ

Example of the type of human tissue we are using to test the drug toxicity and efficacy in our Microfluidic (Organ on Chip) technologies before human trials


OUR CULTURE

To succeed in our mission, we have also built a strong culture based on 3 major axes :

High sense of humor and really hardworker.

Respect for the chain of command and sincere feedback in both directions.

Speed of execution and the pleasure of sharing time with everyone.

Cherry-Biotech_Corporate-values


Cherry Biotech_team_Paris-Eiffel Tower

OUR VALUES

Humor

Cooperation

Surpassing yourself

This is a unique website which will require a more modern browser to work! Please upgrade today!